Risk of fracture with dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodiumglucose cotransporter-2 inhibitors in real-world use: systematic review and meta-analysis of observational studies - Hidayat, K; Du, X; Shi, B M (Osteoporos Int, 2019)